NOVAQUEST PHARMA OPPORTUNITIES FUND V (DELAWARE), L.P.

549300Z5QWU0S741N450

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: Limited Partnership (T91T)
Jurisdiction: US-DE
Entity created: May 23, 2017

Address

Country: United States
Legal address: C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 1209 ORANGE ST19801 WILMINGTONUnited States (US-DE)
Head office: C/O NOVAQUEST CAPITAL MANAGEMENT, L.L.C, 4208 SIX FORKS ROAD, SUITE 92027609 RALEIGHUnited States (US-NC)

Identifier

LEI: 549300Z5QWU0S741N450
Registered: August 13, 2021 at 03:30 PM UTC
Last updated: July 13, 2026 at 09:19 AM UTC
Next renewal: August 12, 2027 at 12:00 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 6420991
Verified against: EDGAR (RA000665)
Verified as: 0001707708
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
Fund managerUnited States5493000LUNI6LGVHU343

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/549300Z5QWU0S741N450This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search